Aaron Royston ^Investor

Aaron Royston, M.D., M.B.A. is a Managing Partner at venBio Partners with a strong background in life science investing, healthcare strategy, and entrepreneurship. He has successfully launched, invested in, and served on the board of multiple companies, leading to the development of five FDA-approved treatments. Dr. Royston's expertise spans from rare genetic diseases to age-related blindness. He holds degrees from Duke University and the University of Pennsylvania, and has received prestigious awards, including the White House Champion of Change Award. His impactful work in technology and innovation has made a significant mark in the healthcare industry. (85 words)